2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Other
1
Lymphoid
1
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
3510
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2499
Leukemia
2362
Leukemia, Lymphocytic, Chronic, B-Cell
1992
Myelodysplastic Syndromes
1412
Hematologic Neoplasms
1385
Lymphoma
1176
Lymphoma, Non-Hodgkin
1079
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
863
Lymphoma, Follicular
761
Multiple Myeloma
739
Lymphoma, Mantle-Cell
730
Lymphoma, Large B-Cell, Diffuse
714
Burkitt Lymphoma
692
Lymphoma, B-Cell, Marginal Zone
645
Hodgkin Disease
636
Recurrence
627
Leukemia, Myelomonocytic, Chronic
536
Neoplasms
519
Lymphoma, Large-Cell, Immunoblastic
451
Myeloproliferative Disorders
445
Leukemia, Myeloid, Chronic-Phase
437
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
414
Congenital Abnormalities
411
Waldenstrom Macroglobulinemia
360
Blast Crisis
353
Leukemia, Myeloid, Accelerated Phase
318
Lymphoma, T-Cell, Cutaneous
311
Primary Myelofibrosis
297
Neoplasms, Plasma Cell
276
Interventions
Eye Movement Desensitization Reprocessing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Obsessive-Compulsive Disorder
×
Other hematologic neoplasm
×
Clear all
NCT06110702
2024-04-16
MDL
University of Pisa
Phase NA
Completed
287 enrolled